Kristen Stants

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Kristen Stants
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Stants:

Company Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Chief People Officer Common Stock 20,264 $243,168 $12.00 30 Nov 2022 Direct

Insider Reports Filed by Kristen Stants

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Magenta Therapeutics, Inc. 30 Nov 2022 1 +$2,820 4 Chief People Officer 02 Dec 2022, 15:19
DNTH Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Chief People Officer 01 Aug 2022, 21:11
DNTH Magenta Therapeutics, Inc. 31 May 2022 1 +$2,970 4 Chief People Officer 06 Jun 2022, 16:06
DNTH Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Chief People Officer 19 May 2022, 16:22
DNTH Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Chief People Officer 17 Feb 2022, 16:20
DNTH Magenta Therapeutics, Inc. 16 Sep 2021 1 -$38,603 4 Chief People Officer 20 Sep 2021, 17:08
DNTH Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 Chief People Officer 16 Sep 2021, 19:42
DNTH Magenta Therapeutics, Inc. 02 Aug 2021 1 $0 4 Chief People Officer 03 Aug 2021, 16:34